156 related articles for article (PubMed ID: 24374343)
21. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
[TBL] [Abstract][Full Text] [Related]
22. RhoGDI SUMOylation at Lys-138 increases its binding activity to Rho GTPase and its inhibiting cancer cell motility.
Yu J; Zhang D; Liu J; Li J; Yu Y; Wu XR; Huang C
J Biol Chem; 2012 Apr; 287(17):13752-60. PubMed ID: 22393046
[TBL] [Abstract][Full Text] [Related]
23. Loss of ARHGDIA expression is associated with poor prognosis in HCC and promotes invasion and metastasis of HCC cells.
Liang L; Li Q; Huang LY; Li DW; Wang YW; Li XX; Cai SJ
Int J Oncol; 2014 Aug; 45(2):659-66. PubMed ID: 24859471
[TBL] [Abstract][Full Text] [Related]
24. A Complete Survey of RhoGDI Targets Reveals Novel Interactions with Atypical Small GTPases.
Ahmad Mokhtar AMB; Ahmed SBM; Darling NJ; Harris M; Mott HR; Owen D
Biochemistry; 2021 May; 60(19):1533-1551. PubMed ID: 33913706
[TBL] [Abstract][Full Text] [Related]
25. Thyroid hormone receptor represses miR-17 expression to enhance tumor metastasis in human hepatoma cells.
Lin YH; Liao CJ; Huang YH; Wu MH; Chi HC; Wu SM; Chen CY; Tseng YH; Tsai CY; Chung IH; Wu TI; Tsai MM; Lin CD; Lin KH
Oncogene; 2013 Sep; 32(38):4509-18. PubMed ID: 23912452
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R
Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745
[TBL] [Abstract][Full Text] [Related]
27. Rock2 regulates Cdc25A through ubiquitin proteasome system in hepatocellular carcinoma cells.
Liu T; Yu X; Li G; Yuan R; Wang Q; Tang P; Wu L; Liu X; Peng X; Shao J
Exp Cell Res; 2012 Oct; 318(16):1994-2003. PubMed ID: 22705122
[TBL] [Abstract][Full Text] [Related]
28. Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression.
Lee TK; Poon RT; Yuen AP; Man K; Yang ZF; Guan XY; Fan ST
Clin Cancer Res; 2006 Sep; 12(17):5082-9. PubMed ID: 16951224
[TBL] [Abstract][Full Text] [Related]
29. Survivin-mediated cancer cell migration through GRP78 and epithelial-mesenchymal transition (EMT) marker expression in Mahlavu cells.
Tai CJ; Chin-Sheng H; Kuo LJ; Wei PL; Lu HH; Chen HA; Liu TZ; Liu JJ; Liu DZ; Ho YS; Wu CH; Chang YJ
Ann Surg Oncol; 2012 Jan; 19(1):336-43. PubMed ID: 21516372
[TBL] [Abstract][Full Text] [Related]
30. Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI-α silencing and overexpression.
Hooshmand S; Ghaderi A; Yusoff K; Thilakavathy K; Rosli R; Mojtahedi Z
Asian Pac J Cancer Prev; 2014; 15(7):3311-7. PubMed ID: 24815488
[TBL] [Abstract][Full Text] [Related]
31. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
32. Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.
Xu X; Liu Z; Zhou L; Xie H; Cheng J; Ling Q; Wang J; Guo H; Wei X; Zheng S
J Exp Clin Cancer Res; 2015 Jan; 34(1):6. PubMed ID: 25609232
[TBL] [Abstract][Full Text] [Related]
33. Integrin
Zhang YL; Xing X; Cai LB; Zhu L; Yang XM; Wang YH; Yang Q; Nie HZ; Zhang ZG; Li J; Zhang XL
J Immunol Res; 2018; 2018():4602570. PubMed ID: 29951557
[TBL] [Abstract][Full Text] [Related]
34. Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation.
Huang D; Du X; Yuan R; Chen L; Liu T; Wen C; Huang M; Li M; Hao L; Shao J
Biochem Biophys Res Commun; 2014 Oct; 453(1):49-56. PubMed ID: 25251472
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
[TBL] [Abstract][Full Text] [Related]
36. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Wang H; Li W; Jin X; Cui S; Zhao L
Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
[TBL] [Abstract][Full Text] [Related]
37. Bif-1 promotes tumor cell migration and metastasis via Cdc42 expression and activity.
Zhang C; Liu F; Chen H; Li N; Luo Z; Guo W; Huang D; Tang S; Wang H; Cheng S; Li Z; Wang H
Clin Exp Metastasis; 2017 Jan; 34(1):11-23. PubMed ID: 27730394
[TBL] [Abstract][Full Text] [Related]
38. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway.
Liu S; Yu M; He Y; Xiao L; Wang F; Song C; Sun S; Ling C; Xu Z
Hepatology; 2008 Jun; 47(6):1964-73. PubMed ID: 18506888
[TBL] [Abstract][Full Text] [Related]
39. Derepression of c-Fos caused by microRNA-139 down-regulation contributes to the metastasis of human hepatocellular carcinoma.
Fan Q; He M; Deng X; Wu WK; Zhao L; Tang J; Wen G; Sun X; Liu Y
Cell Biochem Funct; 2013 Jun; 31(4):319-24. PubMed ID: 23001723
[TBL] [Abstract][Full Text] [Related]
40. Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway.
He J; Cai L; Chen Y; He Y; Wang M; Tang J; Guan H; Wang J; Peng X
Radiother Oncol; 2018 Oct; 129(1):30-37. PubMed ID: 29519627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]